日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

SLC2A1 is a Diagnostic Biomarker Involved in Immune Infiltration of Colorectal Cancer and Associated With m6A Modification and ceRNA

SLC2A1是一种诊断生物标志物,参与结直肠癌的免疫浸润,并与m6A修饰和ceRNA相关。

Liu, Xu-Sheng; Yang, Jian-Wei; Zeng, Jing; Chen, Xue-Qin; Gao, Yan; Kui, Xue-Yan; Liu, Xiao-Yu; Zhang, Yu; Zhang, Yao-Hua; Pei, Zhi-Jun

Comprehensive Analysis of SLC17A9 and Its Prognostic Value in Hepatocellular Carcinoma.

SLC17A9 的综合分析及其在肝细胞癌中的预后价值

Kui Xue-Yan, Gao Yan, Liu Xu-Sheng, Zeng Jing, Yang Jian-Wei, Zhou Lu-Meng, Liu Xiao-Yu, Zhang Yu, Zhang Yao-Hua, Pei Zhi-Jun

Comprehensive Analysis of YTHDF1 Immune Infiltrates and ceRNA in Human Esophageal Carcinoma

人食管癌中YTHDF1免疫浸润和ceRNA的综合分析

Liu, Xu-Sheng; Kui, Xue-Yan; Gao, Yan; Chen, Xue-Qin; Zeng, Jing; Liu, Xiao-Yu; Zhang, Yu; Zhang, Yao-Hua; Pei, Zhi-Jun

Corrigendum: NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis

更正:NPM1 是一种预后生物标志物,参与肺腺癌的免疫浸润,并与 m6A 修饰和糖酵解相关。

Liu, Xu-Sheng; Zhou, Lu-Meng; Yuan, Ling-Ling; Gao, Yan; Kui, Xue-Yan; Liu, Xiao-Yu; Pei, Zhi-Jun

NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis.

NPM1 是一种预后生物标志物,参与肺腺癌的免疫浸润,并与 m6A 修饰和糖酵解相关

Liu Xu-Sheng, Zhou Lu-Meng, Yuan Ling-Ling, Gao Yan, Kui Xue-Yan, Liu Xiao-Yu, Pei Zhi-Jun

Comprehensive Analysis of GLUT1 Immune Infiltrates and ceRNA Network in Human Esophageal Carcinoma

人食管癌中GLUT1免疫浸润和ceRNA网络的综合分析

Liu, Xu-Sheng; Gao, Yan; Wu, Li-Bing; Wan, Hua-Bing; Yan, Peng; Jin, Yang; Guo, Shi-Bo; Wang, Ya-Lan; Chen, Xue-Qin; Zhou, Lu-Meng; Yang, Jian-Wei; Kui, Xue-Yan; Liu, Xiao-Yu; Pei, Zhi-Jun

Comprehensive Analysis of Prognostic and Immune Infiltrates for E2F Transcription Factors in Human Pancreatic Adenocarcinoma

人胰腺腺癌中E2F转录因子预后和免疫浸润的综合分析

Liu, Xu-Sheng; Gao, Yan; Liu, Chao; Chen, Xue-Qin; Zhou, Lu-Meng; Yang, Jian-Wei; Kui, Xue-Yan; Pei, Zhi-Jun